Emerging Agents in the Pipeline for Merkel Cell Carcinoma
3 vistas
• 07/17/23
0
0
Empotrar
administrator
Suscriptores
Howard L. Kaufman, MD, FACS, chief surgical officer and associate director for clinical science at Rutgers Cancer Institute of New Jersey, discusses emerging agents in the pipeline for Merkel cell carcinoma.
Mostrar más
Comentarios de Facebook
SORT BY-
Top Comentarios
-
Últimos comentarios